Andrea Denicoff is a Nurse Consultant in the Clinical Investigations Branch within the Cancer Therapy Evaluation Program (CTEP) in the Division of Cancer Treatment & Diagnosis at the National Cancer Institute (NCI). She directs, manages, and coordinates several projects within CTEP’s Clinical Trials Cooperative Group Program, including components of the Cancer Trials Support Unit (CTSU). She serves as the lead clinical trials advisor to NCI’s pilot National Community Cancer Centers Program (NCCCP) that has a major goal of increasing underrepresented populations and minorities onto trials. Provides leadership and coordination for health-related quality of life (HRQoL) research in cancer treatment studies, serves on NCI’s Symptom Management and HRQoL Scientific Steering Committee, and is a CTEP reviewer of health-related quality of life endpoints and patient reported outcomes in cancer trials. In addition, she coordinates palliative care initiatives at the NCI and chairs the NCI’s Palliative Care Working Group. Before coming to the NCI, she was on the faculty at Georgetown University in the Department of Medicine, Division of Hematology/ Oncology. Prior to that, she was the research nurse coordinating early phase breast cancer trials for the Medical Breast Cancer Section in NCI’s intramural program.
National Cancer Institute
6130 Executive Blvd., Suite 7025
Bethesda, MD 20892-7436